scholarly article | Q13442814 |
P50 | author | Rachel Pascoe | Q58910611 |
Paul Urquhart Cameron | Q67957474 | ||
Renee M van der Sluis | Q37369246 | ||
Sharon R. Lewin | Q37618308 | ||
P2093 | author name string | Vanessa A Evans | |
Nitasha A Kumar | |||
Talia Mota | |||
P2860 | cites work | Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection | Q22251080 |
Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway | Q24523390 | ||
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms | Q24534904 | ||
IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV | Q24567990 | ||
HIV restriction in quiescent CD4⁺ T cells | Q26995784 | ||
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases | Q28237805 | ||
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Q28253761 | ||
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure | Q28283258 | ||
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation | Q29619611 | ||
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. | Q30515733 | ||
HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response | Q33508241 | ||
Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections | Q33573749 | ||
Segmental duplication as one of the driving forces underlying the diversity of the human immunoglobulin heavy chain variable gene region | Q33805553 | ||
Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy | Q33816010 | ||
Vpr-host interactions during HIV-1 viral life cycle | Q33828332 | ||
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys | Q34020988 | ||
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells | Q34059612 | ||
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli | Q34124009 | ||
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. | Q34165677 | ||
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation | Q34331884 | ||
The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest | Q34480135 | ||
HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection | Q34502840 | ||
HIV infection and the gastrointestinal immune system | Q34601874 | ||
TIM-3 does not act as a receptor for galectin-9. | Q34649690 | ||
Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes | Q34649701 | ||
HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells | Q34672568 | ||
An in vitro system to model the establishment and reactivation of HIV-1 latency. | Q51960585 | ||
CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. | Q51971372 | ||
A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. | Q51980078 | ||
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. | Q52007779 | ||
In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. | Q52050894 | ||
The pathway to establishing HIV latency is critical to how latency is maintained and reversed. | Q54237426 | ||
Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR Vβ gene products | Q56797391 | ||
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency | Q58003757 | ||
Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells | Q88866382 | ||
Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells | Q34699537 | ||
Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells | Q35067224 | ||
HIV-1 integration landscape during latent and active infection | Q35211469 | ||
Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma | Q35822484 | ||
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells | Q36053889 | ||
Dendritic cells are potent antigen-presenting cells for microbial superantigens | Q36230868 | ||
Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells | Q36287580 | ||
Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir | Q36318184 | ||
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses | Q36362098 | ||
Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells | Q36404256 | ||
p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells | Q36434375 | ||
Identification of T cell-signaling pathways that stimulate latent HIV in primary cells | Q36690000 | ||
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells | Q37039142 | ||
CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure | Q37059664 | ||
High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. | Q37123276 | ||
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA. | Q37493334 | ||
HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy | Q37643783 | ||
Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection | Q37700859 | ||
Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics | Q37737052 | ||
Origins of CD4(+) effector and central memory T cells | Q37899115 | ||
Molecular signatures of T-cell inhibition in HIV-1 infection | Q38091548 | ||
CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes | Q38889611 | ||
Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB. | Q39026635 | ||
A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cells. | Q39170271 | ||
Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction | Q39712159 | ||
Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells | Q39810780 | ||
Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels | Q41456104 | ||
Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4⁺ memory T Cells | Q41670052 | ||
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. | Q41880147 | ||
Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children | Q42245629 | ||
CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency | Q42573954 | ||
Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. | Q43154827 | ||
Functional antigen-independent synapses formed between T cells and dendritic cells | Q43740483 | ||
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). | Q45745522 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
dendritic cell | Q506253 | ||
P304 | page(s) | 1468-1477 | |
P577 | publication date | 2018-07-20 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells | |
P478 | volume | 201 |
Q89935915 | Diverse effects of interferon alpha on the establishment and reversal of HIV latency |
Q91593126 | HIV Infection Stabilizes Macrophage-T Cell Interactions To Promote Cell-Cell HIV Spread |
Q92479178 | Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection |
Q64985976 | Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir. |
Q90479627 | Myeloid Cells Enriched for a Dendritic Cell Population From People Living With HIV Have Altered Gene Expression Not Restored by Antiretroviral Therapy |
Q92441659 | Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill |
Q92216465 | Strength of T cell signaling regulates HIV-1 replication and establishment of latency |
Search more.